ABSTRACT SUBMISSION DEADLINE EXTENDED TO SEPTEMBER 28, 2020

Late breaker deadline :
on request – strict conditions to be complied with.

All abstracts must be submitted through the online abstract submission system.

GENERAL CONDITIONS FOR SUBMISSION OF ABSTRACTS

Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2021 Congress and has adequate financial resources to attend.

1. Authors are requested to register within 10 days after having received their provisional notification of acceptance.
   
   Abstracts of authors not registered by September 28, 2020 will not be taken into consideration for the final program.
   
   Abstract presenters who would like to benefit from the early bird registration rate (deadline is September 8) are advised to submit their abstract before September 8, 2020 and send a short notice to admin@eurogin.com
   
   They will then receive notification of acceptance/refusal which will allow them to register at the early bird rate.
   
   If the abstract presenter is registered with a group, please inform the Congress Secretariat at: admin@eurogin.com and indicate the person who booked the group registration.
2. Abstracts must be submitted and presented in ENGLISH
   
3. Abstracts should be prepared in accordance to the instructions below and submitted through the online system. Abstracts should comply with the editing instructions;
   
4. For proffered papers (for Oral Communications sessions or Poster presentation), only ONE abstract is allowed per person duly registered for the congress;
   
5. Original scientific material is welcome and preference is given to recent findings not yet published at the date of the Congress;
   
6. Abstracts will be peer reviewed and evaluated by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation;
   
7. The final decision of the Scientific Committee will be announced early September 2020.
   
8. Authors agree that their abstract will be published in the congress abstract book (pdf document, no printed document will be issued)
   
9. All accepted abstract submitters will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract, as well as the email addresses of the main author and the presenter (the author who will present the paper at the conference).
   
   The main author and the presenter can be the same person. They may also be identical to or different from the submitter);
   
10. The main author and the presenter must be identified (by ticking the corresponding boxes)
    
11. For further information and assistance please contact the scientific secretariat at admin@eurogin.com
    

ABSTRACT EDITING INSTRUCTIONS

1. Abstracts must be submitted through the online submission system.
2. Maximum length (body of abstract): 2700 characters (spaces included).
   
3. The title should be written in UPPER CASE (capitals); (keep it as short as possible, clearly indicating the nature of the investigation.
   
4. Please avoid complex mathematical formulae; the system allows to insert simple tables.
   
5. Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned.
   
6. All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract.
   
7. Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered.
   
8. Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles.
   
9. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature.
   
10. Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them.
    
11. Drugs must be identified by their generic names and no company names should be mentionned in the title of the abstract.
    

ABSTRACT TOPICS

For review purposes, abstracts are classified according to the following list.
Select only 1 topic on our submission form:

1. Viral and molecular biology
2. Epidemiology and natural history
3. Pathogenesis
4. Immunology
5. HPV prophylactic vaccines
6. HPV therapeutic vaccines
7. Immunotherapy - Immuno-oncology - New treatments
8. HPV testing
9. HPV screening
10. Self-sampling
11. Genotyping
12. Molecular markers
13. Screening for women difficult to reach
14. Screening methods
15. Liquid based cytology
16. Automation in cytology
17. Methylation
18. Microbiome
19. Serology
20. New technologies
21. Artificial Intelligence
22. Diagnostic procedures / management
23. Colposcopy
24. Cervical neoplasia
25. Vaginal neoplasia
26. Vulvar diseases and neoplasia
27. Anal neoplasia
28. Oral HPV infection
29. HPV and oropharynx / Head and neck cancer
30. HPV and associated skin diseases
31. Genital warts
32. Sexually transmitted diseases and HIV infection
33. Conventional therapies
34. Economics and modelling
35. Advocacy, acceptability and psychology
36. Health education
37. Low resource settings
38. Public health
39. Fertility and HPV